发明名称 |
Hydrophilic self-immolative linkers and conjugates thereof |
摘要 |
The present disclosure provides compounds with a hydrophilic self-immolative linker, which is cleavable under appropriate conditions and incorporates a hydrophilic group to provide better solubility of the compound. The compounds of the present disclosure comprise a drug moiety, a targeting moiety capable of targeting a selected cell population, and a linker which contains an acyl unit, an optional spacer unit for providing distance between the drug moiety and the targeting moiety, a peptide linker which can be cleavable under appropriate conditions, a hydrophilic self-immolative linker, and an optional second self-immolative spacer or cyclization self-elimination linker. |
申请公布号 |
US9089614(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201314137799 |
申请日期 |
2013.12.20 |
申请人 |
BioAlliance C.V.;AbGenomics International Inc. |
发明人 |
Lin Rong-Hwa;Lin Shih-Yao;Hsieh Yu-Chi;Huang Chiu-Chen |
分类号 |
A61K47/48;C07D241/36 |
主分类号 |
A61K47/48 |
代理机构 |
Morrison & Foerster LLP |
代理人 |
Morrison & Foerster LLP |
主权项 |
1. A compound of the formula (II): or a salt or solvate or stereoisomer thereof; wherein: D is a drug moiety; T is a targeting moiety; R1 is hydrogen, unsubstituted or substituted C1-3 alkyl, or unsubstituted or substituted heterocyclyl; L1 is a bond, a second self-immolative linker, or a cyclization self-elimination linker; L2 is a bond or a second self-immolative linker;
wherein if L1 is a second self-immolative linker or a cyclization self-elimination linker, then L2 is a bond;wherein if L2 is a second self-immolative linker, then L1 is a bond; L3 is a peptide linker; L4 is bond or a spacer; and A is an acyl unit. |
地址 |
Alkmaar NL |